Shares of Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH – Get Free Report) shot up 3.8% during mid-day trading on Friday . The company traded as high as $0.44 and last traded at $0.42. Approximately 130,742 shares changed hands during mid-day trading, a decline of 71% from the average daily volume of 455,928 shares. The stock had previously closed at $0.41.
Shuttle Pharmaceuticals Stock Performance
The company has a market cap of $2.07 million, a price-to-earnings ratio of -0.10 and a beta of -1.63. The business’s 50 day simple moving average is $0.66 and its 200-day simple moving average is $0.97.
Shuttle Pharmaceuticals Company Profile
Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .
Recommended Stories
- Five stocks we like better than Shuttle Pharmaceuticals
- 3 Small Caps With Big Return Potential
- FedEx Delivers Another Crushing Blow to Its Stock Price
- What is the Australian Securities Exchange (ASX)
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Investing In Preferred Stock vs. Common Stock
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Shuttle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shuttle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
